M.D.C. Holdings, Inc. (NYSE:MDC) has been given a consensus rating of “Hold” by the nine analysts that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $33.83.
Several research analysts have recently issued reports on MDC shares. Zacks Investment Research cut M.D.C. from a “hold” rating to a “sell” rating in a research note on Tuesday, January 15th. ValuEngine cut M.D.C. from a “hold” rating to a “sell” rating in a research note on Tuesday, January 22nd.
NYSE MDC traded down $0.53 during trading on Wednesday, hitting $29.06. The company’s stock had a trading volume of 441,583 shares, compared to its average volume of 366,886. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.49 and a current ratio of 9.15. The company has a market cap of $1.82 billion, a PE ratio of 7.92, a P/E/G ratio of 1.11 and a beta of 1.34. M.D.C. has a fifty-two week low of $25.14 and a fifty-two week high of $33.47.
In other news, COO David D. Mandarich sold 35,224 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $28.52, for a total value of $1,004,588.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director David E. Blackford sold 4,000 shares of M.D.C. stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $28.51, for a total value of $114,040.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 194,089 shares of company stock valued at $5,611,678. Company insiders own 26.30% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the stock. BlackRock Inc. raised its position in M.D.C. by 0.7% during the third quarter. BlackRock Inc. now owns 7,983,118 shares of the construction company’s stock valued at $236,141,000 after acquiring an additional 56,428 shares in the last quarter. CVentures Inc. purchased a new position in M.D.C. during the fourth quarter valued at approximately $206,427,000. Vanguard Group Inc. raised its position in M.D.C. by 1.1% during the third quarter. Vanguard Group Inc. now owns 5,408,996 shares of the construction company’s stock valued at $159,998,000 after acquiring an additional 57,224 shares in the last quarter. Vanguard Group Inc raised its position in M.D.C. by 1.1% during the third quarter. Vanguard Group Inc now owns 5,408,996 shares of the construction company’s stock valued at $159,998,000 after acquiring an additional 57,224 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in M.D.C. by 0.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 4,761,297 shares of the construction company’s stock valued at $133,841,000 after acquiring an additional 14,715 shares in the last quarter. Institutional investors own 84.59% of the company’s stock.
M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.
Recommended Story: How to Track your Portfolio in Google Finance
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.